June 9, 2026/
To separate signal from noise, the Uppsala Monitoring Centre (UMC) developed VigiGrade—a tool that assigns a completeness score to every single ICSR.
ALVigiLance is a dedicated pharmacovigilance platform designed to support the healthcare team in ensuring safer medication use. Our mission is simple yet vital: to provide trusted insights, practical tools, and up-to-date resources that empower healthcare professionals to identify, prevent, and manage adverse drug reactions (ADRs).
Simplified, practical guides on drug safety and monitoring.
Real-world examples to strengthen your clinical decision-making.
Summaries of global drug warnings and regulatory actions.
Strategies for adverse event reporting, risk management, and patient counseling.
To create a proactive community of healthcare providers who champion medication safety and improve patient outcomes through shared knowledge and vigilance.
Medication safety is everyone’s responsibility. Explore, learn, and engage with ALVigiLance — because together, we can reduce risks and save lives.
To separate signal from noise, the Uppsala Monitoring Centre (UMC) developed VigiGrade—a tool that assigns a completeness score to every single ICSR.
Most pharmacovigilance (PV) teams obsess over the seven-day and fifteen-day reporting deadlines, yet they overlook a far more insidious window—the first 48 hours after safety information...
Regulatory update on isotretinoin prescribing requirements, a detailed local case safety report documenting posterior reversible encephalopathy syndrome (PRES) in two pediatric oncology patients receiving cyclophosphamide-containing chemotherapy.
